casibom deneme bonusu betforward-shart.com 1xbet-1xir.com Betturkey giriş casibom Antiviral – Page 2 – Ferozsons Laboratories Limited

Ferozsons Laboratories Limited

  • LANGUAGES
    • English English
    • اردو اردو
  • About Us
    • History
    • Company Profile
    • Vision, Mission & Values
    • Message From CEO
    • Board of Directors
    • Contact Us
  • Partnerships
  • Product Portfolio
    • Product List
    • Pharmaceuticals
    • Medical Technologies
    • Exports
  • Investors
    • Company Profile
    • Governance
      • Corporate Briefing Session
        • Notice of Corporate Briefing Session 2024
        • Corporate Briefing Session Presentation 2024
      • AGM 28-10-2024
      • Board of Directors
      • Shareholding Pattern
      • Name of Auditor & Legal Advisor
    • Video Message from CEO
    • Investor Relations
      • Online Form & Contact Person
      • Notices of General Meetings, Dividend / Bonus Declarations
      • Sitemap
      • Search
    • Media
      • Awards
      • Memberships
      • News & Updates
      • Website Last Updated
    • Election of Directors
      • Notice of Election of Directors
      • Detail of Submitted Proxies
      • Profile of Contesting Candidates
      • List of Shareholders
      • Proxy Form
      • Ballot Paper
    • Investor Information
      • PSX Symbol
      • Financial Ratios
      • Statement on Gender Pay Gap
      • Share Registrar
      • Free Float 31-03-2024
      • Code of Conduct
    • Shareholding Information
      • List of Non CNIC Shareholders
      • List of Unclaimed Dividends And Shares
      • Share Price
    • Financial Statements
      • Annual Reports
      • Interim Accounts
      • Financial Reports
    • Compliance Certificate
    • EHS Policy
    • Quality Policy
  • Patients
    • Disease Info
    • Drug Safety
    • Send Query
  • Physicians
  • CSR
  • Press & Media
    • Videos
    • Statement on Remdesivir
    • Statement on Lenacapavir
  • Home
  • Product
  • Page 2
May 9, 2025

Therapeutic: Antiviral

Empagen-M XR

Wednesday, 01 March 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments

Empagen-L

Tuesday, 28 February 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments

Ertuvia

Monday, 27 February 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments

Ertuvia – S

Sunday, 26 February 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments

Ertuvia – M

Sunday, 26 February 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments

Hecolin

Monday, 20 February 2023 by developers

FEROZSONS LABORATORIES LIMITED

Read more
No Comments

Noxane

Sunday, 12 February 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments

Ubetril

Sunday, 29 January 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments

Viktana

Wednesday, 25 January 2023 by developers

Ferozsons Laboratories Limited

Read more
No Comments
  • 1
  • 2
  • About Us

  • Profile of the Company
  • Board of Directors
  • Our Vision, Mission & Values Statement
  • History
  • Message from CEO
  • Contact Us

  • Partnerships

  • Patients

  • Disease Info
  • Send Query
  • Drug Safety
  • Physicians

  • CSR

  • Careers

  • Products Portfolio

  • Pharma & OTC
  • Medical Technologies
  • Exports
  • Investors

  • Awards
  • Election of Directors
  • Investor Information

    Registered Office

    Ferozsons Laboratories Limited 197-A,
    The Mall,Rawalpindi,Rawalpindi-42000
    +92-51-4252150-53/55
    +92-51-4252152-57
    www.ferozsons-labs.com
    info@ferozsons-labs.com

    Head Office

    5 KM Sundar Raiwind Road, Raiwind,
    Lahore, Pakistan
    +92-42-36026700
    +92-42-36026702
    info@ferozsons-labs.com, info@bfbio.com

    Pharma Factory

    P.O.Ferozsons, Amangarh - Nowshera
    (Khyber Pakhtunkhwa)
    +92-923-614295, 610159
    +92-923-611302
    info@ferozsons-labs.com

   

© Copyright Ferozsons Laboratories Limited 2004 - 2024 all rights reserved.
Designed & Developed by A2Z Creatorz
Design Update by David Torrone & Athanasios Anagnostopoulos

TOP